EGFR and androgen insensitivity syndrome: These data suggest that although EGFR 19del, L858R, and 20ins are driver mutations in lung adenocarcinoma, EGFR 20ins were more frequently altered in preinvasive AIS, whereas EGFR 19del and L858R were frequently altered in invasive tumors.